Project Description
Maculaser
Maculaser ERG-based technology enables real-time and personalized control of the temperature of the retina during non-damaging ophthalmic laser treatments.
The industry-disruptive goal is disease prevention by providing effective and safe laser treatments for retinal disorders that impact the everyday life of millions of people worldwide.
Maculaser joined NOME in 2022 and is led by Jani Tirronen.
